If you or someone you know has chronic asthma do read this article to know how biologics can potentially help in treating the condition ...

All participants will initially undergo a run-in period on standardised medium-dose ICS/LABA to confirm persistent lack of ...

The poster presentations will be available on Connect’s website under the Presentations and Publications section.

Patients with moderate to severe asthma saw increases in FEV1 within 24 hours after taking a loading dose of rademikibart, ...

Children with asthma experienced fewer exacerbations and better control with dupilumab regardless of the duration of their ...

A new study published in the Journal of the European Academy of Dermatology and Venerology found dupilumab to have a ...

FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial shows significant symptom reduction ...

New findings suggest asthma may be reversible in some cases, offering hope for long-term remission and a shift in treatment ...

The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...

Asthma is a chronic condition that never completely goes away, but you can manage your symptoms and achieve remission. According to the Centers for Disease Control and Prevention (CDC), an ...

Open Airways marked World Asthma Day with an asthma education seminar at City Hall in Hamilton. A Government spokesperson said, “Open Airways today hosted an asthma education seminar at City ...

World Asthma Day is celebrated every year on the first Tuesday of May to raise awareness about asthma and help improve the lives of people dealing with the condition. In 2025, this day will fall on ...